NAACCR Item #3857: High Risk Cytogenetics
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3857 | 1 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | highRiskCytogenetics | Tumor |
Required Status:
NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Required, site specific
CCCR Collect: Required, site specific; when available
Description
High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma.
Rationale
High Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 *Plasma Cell Myeloma and Plasma Cell Disorders*, for staging of plasma cell myeloma.
Allowable Values
0, 1, 5, 7, 9
Codes
| Code | Description |
|---|---|
| 0 | High-risk cytogenetics not identified/not present |
| 1 | High-risk cytogenetics present |
| 5 | Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 |
| 7 | Test ordered, results not in chart |
| 9 | Not documented in medical record High Risk Cytogenetics not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.